Atlas

Form 483

Henry A Frazer, Pharm D, Clinical Investigator Form 483, 2012-10-03

FDA issued a Form 483 to Henry A Frazer, Pharm D, Clinical Investigator on 2012-10-03 with 2 public-safe observations.

483· Form 483 issued2 observations

Henry A Frazer, Pharm D, Clinical Investigator · Montgomery, United States · Issued October 3, 2012

Overview

  • 2 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

3 Oct 2012
21 CFR 312.60

FD-1572, protocol compliance

Cited by Kimberly Dutzek

3 Oct 2012
21 CFR 312.62(b)

Case history records- inadequate or inadequate

Cited by Kimberly Dutzek

Inspected site

HAHenry A Frazer, Pharm D, Clinical InvestigatorMontgomery, United States

Inspection team

KDKimberly Dutzek

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 312.60Cited across public-safe Form 483 observations1x
21 CFR 312.62(b)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Book a demoStart a free trial

Full 483 report

Get the verbatim text of all 2 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere